Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 251-256

  Peitl, Barna ^a   Döbrönte, Róbert ^b,c   Drimba, László ^a   Sári, Réka ^a   Varga, Angelika ^a   Németh, József ^a   Pázmány, Tamás ^d   Szilvássy, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Endocrinology and Diabetology   (Hungary)

^c Dept of Anesthesiology   (Germany)

^d Cerorin Ltd   (Hungary)

Author keywords

CCK 1 receptor; Hyperinsulinaemic euglycaemic glucose clamping; Insulin sensitivity; Otsuka Long Evans Tokushima Fatty rat; Proglumide; Rapid insulin sensitivity test

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; GLUCOSE; INSULIN; MESSENGER RNA; PROGLUMIDE; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONG EVANS RAT; MALE; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; WEIGHT GAIN;

ANIMALS; CHOLECYSTOKININ; GENE EXPRESSION REGULATION; GLUCOSE CLAMP TECHNIQUE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; POLYMERASE CHAIN REACTION; POSTPRANDIAL PERIOD; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; THIAZOLIDINEDIONES;

EID: 77955770868     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.062     Document Type: Article

References (42)

1. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006, 131:640-658.
2. Clerc P., Coll Constans M.G., Lulka H., Broussaud S., Guigne C., Leung-Theung-Long S., Perrin C., Knauf C., Carpene C., Penicaud L., Seva C., Burcelin R., Valet P., Fourmy D., Dufresne M. Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology 2007, 148:1039-1049.
3. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides 1994, 15:731-755.
4. Cutfield W.S., Jefferies C.A., Jackson W.E., Robinson E.M., Hofman P.L. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr. Diabetes 2003, 4:119-125.
5. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979, 237:E214-E223.
6. Dockray G.J. Cholecystokinin and gut-brain signalling. Regul. Pept. 2009, 155:6-10.
7. Dockray G.J. The versatility of the vagus. Physiol. Behav. 2009, 97:531-536.
8. Funakoshi A., Miyasaka K., Shinozaki H., Masuda M., Kawanami T., Takata Y., Kono A. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem. Biophys. Res. Commun. 1995, 210:787-796.
9. Herczeg L., Buherenkova T., Szilvassy Z., Peitl B. Diabetes induced by partial hepatic sensory denervation in conscious rabbits. Eur. J. Pharmacol. 2007, 568:287-288.
10. Herranz R. Cholecystokinin antagonists: pharmacological and therapeutic potential. Med. Res. Rev. 2003, 23:559-605.
11. Jia D.M., Fukumitsu K.I., Tabaru A., Akiyama T., Otsuki M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R1332-R1340.
12. Kawano K., Hirashima T., Mori S., Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res. Clin. Pract. 1994, 24(Suppl):S317-S320.
13. Kearney M.T., Charlesworth A., Cowley A.J., Macdonald I.A. William Heberden revisited: postprandial angina-interval between food and exercise and meal composition are important determinants of time to onset of ischemia and maximal exercise tolerance. J. Am. Coll. Cardiol. 1997, 29:302-307.
14. Latour M.G., Lautt W.W. The hepatic vagus nerve in the control of insulin sensitivity in the rat. Auton. Neurosci. 2002, 95:125-130.
15. Lautt W.W. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can. J. Physiol. Pharmacol. 1999, 77:553-562.
16. Lautt W.W., Wang X., Sadri P., Legare D.J., Macedo M.P. Rapid insulin sensitivity test (RIST). Can. J. Physiol. Pharmacol. 1998, 76:1080-1086.
17. Liddle R.A., Carter J.D., McDonald A.R. Dietary regulation of rat intestinal cholecystokinin gene expression. J. Clin. Invest. 1988, 81:2015-2019.
18. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Moore M.C., Satake S., Baranowski B., Hsieh P.S., Neal D.W., Cherrington A.D. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E286-E296.
21. Moran T.H. Unraveling the obesity of OLETF rats. Physiol. Behav. 2008, 94:71-78.
22. Moran T.H., Kinzig K.P. Gastrointestinal satiety signals II. Cholecystokinin. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G183-G188.
23. Naslund E., Hellstrom P.M. Appetite signaling: from gut peptides and enteric nerves to brain. Physiol. Behav. 2007, 92:256-262.
24. Norlen P., Ericsson P., Kitano M., Ekelund M., Hakanson R. The vagus regulates histamine mobilization from rat stomach ECL cells by controlling their sensitivity to gastrin. J. Physiol. 2005, 564:895-905.
25. Peitl B., Szilvassy Z. The inhibitory effect of proglumide on meal-induced insulin sensitization in rats. Metabolism 2007, 56:863-864.
26. Peitl B., Dobronte R., Nemeth J., Mezey G., Kovacs P., Paragh G., Szilvassy Z. The prandial insulin sensitivity-modifying effect of vagal stimulation in rats. Metabolism 2005, 54:579-583.
27. Peitl B., Nemeth J., Pankucsi C., Szilvassy Z. Insulin sensitization induced by oral cicletanine in conscious rabbits. Naunyn Schmiedebergs Arch. Pharmacol. 2006, 373:429-439.
28. Peitl B., Dobronte R., Nemeth J., Pankucsi C., Sari R., Varga A., Szilvassy Z. Meal-induced enhancement in insulin sensitivity is not triggered by hyperinsulinemia in rats. Metabolism 2009, 58:328-332.
29. Porszasz R., Legvari G., Nemeth J., Literati P.N., Szolcsanyi J., Szilvassy Z. The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits. Eur. J. Pharmacol. 2002, 443:211-212.
30. Porszasz R., Legvari G., Pataki T., Szilvassy J., Nemeth J., Kovacs P., Paragh G., Szolcsanyi J., Szilvassy Z. Hepatic insulin sensitizing substance: a novel 'sensocrine' mechanism to increase insulin sensitivity in anaesthetized rats. Br. J. Pharmacol. 2003, 139:1171-1179.
31. Quon M.J. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J. Clin. Endocrinol. Metab. 2001, 86:4615-4617.
32. Reid M.A., Latour M.G., Legare D.J., Rong N., Lautt W.W. Comparison of the rapid insulin sensitivity test (RIST), the insulin tolerance test (ITT), and the hyperinsulinemic euglycemic clamp (HIEC) to measure insulin action in rats. Can. J. Physiol. Pharmacol. 2002, 80:811-818.
33. Reidelberger R.D. Cholecystokinin and control of food intake. J. Nutr. 1994, 124:1327S-1333S.
34. Rushakoff R.A., Goldfine I.D., Beccaria L.J., Mathur A., Brand R.J., Liddle R.A. Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia. J. Clin. Endocrinol. Metab. 1993, 76:489-493.
35. Sadri P., Legare D.J., Lautt W.W. Insulin resistance caused by nitric oxide synthase inhibition. Proc. West. Pharmacol. Soc. 1997, 40:19-20.
36. Starrenburg F.C., Bogers J.P. How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur. Psychiatry 2009, 24:164-170.
37. Szilvassy J., Sziklai I., Sari R., Nemeth J., Peitl B., Porszasz R., Lonovics J., Szilvassy Z. Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy. Eur. J. Pharmacol. 2006, 531:217-225.
38. Takiguchi S., Takata Y., Funakoshi A., Miyasaka K., Kataoka K., Fujimura Y., Goto T., Kono A. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 1997, 197:169-175.
39. Varga A., Bagossi P., Tozser J., Peitl B., Szilvassy Z. Effect of experimental hypercholesterolaemia on K+ channel alpha-subunit mRNA levels in rabbit hearts. Eur. J. Pharmacol. 2007, 562:130-131.
40. Verspohl E.J., Ammon H.P., Williams J.A., Goldfine I.D. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes 1986, 35:38-43.
41. Wallace T.M., Matthews D.R. The assessment of insulin resistance in man. Diabet. Med. 2002, 19:527-534.
42. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ. Res. 1980, 47:1-9.